Comment in

• Nalmefene in alcohol misuse: junk evaluation by the European Medicines Agency.

  Braillon A. Braillon A. BMJ. 2014 Mar 10;348:g2017. doi: 10.1136/bmj.g2017. BMJ. 2014. PMID: 24614566 No abstract available.
• Bad medicine: using surrogate markers.

  McNulty SJ, Williams P. McNulty SJ, et al. BMJ. 2014 Mar 10;348:g2012. doi: 10.1136/bmj.g2012. BMJ. 2014. PMID: 24614808 No abstract available.
• Wim van den Brink and colleagues reply to Des Spence and Alain Braillon.

  van den Brink W, Mann K, Gual A, Aubin HJ. van den Brink W, et al. BMJ. 2014 Apr 7;348:g2605. doi: 10.1136/bmj.g2605. BMJ. 2014. PMID: 24711667 No abstract available.